Gargi Patel
Allergy & Immunology · Piscataway, NJNPI 1740727411
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Ionis Pharmaceuticals, Inc. at 44.9% of the total. 2025 is the largest year on record at $9,414, more than ten times the $49 reported in 2019.
Across 279 payments — averaging $44.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ionis Pharmaceuticals, Inc.$6K
- Sanofi$3K
- AstraZeneca$602
- GSK$462
- Genentech USA, Inc.$394
- Novartis$235
- plus $2K from 24 others
What the payments were for
- Consulting fees$1,71914%
- Speaking & faculty fees$5,40043%
- Food & beverage$5,23842%
- Education$881%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ionis Pharmaceuticals, Inc. | 8 | $5,582 |
| Sanofi | 61 | $3,351 |
| AstraZeneca | 26 | $602 |
| GSK | 38 | $462 |
| Genentech USA, Inc. | 25 | $394 |
| Novartis | 13 | $235 |
| CSL Behring | 9 | $179 |
| ARS Pharmaceuticals Operations, Inc. | 12 | $179 |
| Pharming Healthcare, Inc. | 12 | $171 |
| Organon | 4 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $148 |
| Biocryst US Sales Co., LLC | 10 | $145 |
| Incyte Corporation | 9 | $143 |
| Regeneron Healthcare Solutions, Inc. | 8 | $111 |
| Pfizer | 6 | $87 |
| Cycle Pharmaceuticals Inc | 3 | $78 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Teva Pharmaceuticals USA, Inc. | 5 | $68 |
| Lilly USA, LLC | 3 | $49 |
| Amgen(2 entities) | 3 | $46 |
| AbbVie | 3 | $39 |
| Galderma Laboratories, L.p. | 2 | $31 |
| Hikma Pharmaceuticals USA | 1 | $24 |
| Kaleo, Inc. | 1 | $17 |
| Phadia US Inc. | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Alk-abello, Inc | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
| Grifols USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,445 in reported general payments places this provider in the 75th percentile of 135 allergy & immunology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 21 | $222,206 |
| XolairOmalizumab | 41 | $131,694 |
| Dupixent SyringeDupilumab | 26 | $101,661 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $10,727 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $6,728 |
| Arnuity ElliptaFluticasone Furoate | 15 | $4,067 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $1,294 |
| Fluticasone Propionate | 52 | $809 |
| Azelastine Hcl | 27 | $502 |
| Levocetirizine Dihydrochloride | 34 | $459 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $438 |
| Montelukast Sodium | 21 | $344 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $179 | $222,20621 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $462 | $21,52144 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 135 allergy & immunology providers in New Jersey.
Other allergy & immunology in Piscataway
- Ellen SherOcean$1M
- Peter RickettiTrenton$457K
- John KimMedford$339K
- Tina ZeccaLittle Silver$262K
- George BelecanechVoorhees$208K
- Jacqueline RossOcean$131K
- Shirin JadidiMendham$98K
- Mark WeinsteinBelleville$88K
- Joseph GrizzantiHawthorne$79K
- Lisa BariscianoFlorham Park$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.